Systemic Immunoglobulin Light Chain Amyloidosis–Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome-Reference-Cited by-同舟云学术

Systemic Immunoglobulin Light Chain Amyloidosis–Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

Published:2016-10 Issue:10 Volume:91 Page:1354-1361
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Muchtar Eli,Derudas Daniele,Mauermann Michelle,Liewluck Teerin,Dispenzieri Angela,Kumar Shaji K.,Dingli David,Lacy Martha Q.,Buadi Francis K.,Hayman Suzanne R.,Kapoor Prashant,Leung Nelson,Chakraborty Rajshekhar,Gonsalves Wilson,Russell Stephen,Lust John A.,Lin Yi,Go Ronald S.,Zeldenrust Steven,Kyle Robert A.,Rajkumar S. Vincent,Gertz Morie A.

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. What do I need to know about immunoglobulin light chain (AL) amyloidosis?;Dispenzieri;Blood Rev,2012

2. Incidence and survival in non-hereditary amyloidosis in Sweden;Hemminki;BMC Public Health,2012

3. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989;Kyle;Blood,1992

4. Systemic light chain amyloidosis: an update for treating physicians;Merlini;Blood,2013

5. Myopathy in primary systemic amyloidosis;Gertz;J Neurol Neurosurg Psychiatry,1996

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Amyloid Myopathy Mimicking Anti-Mi-2 Antibody-Positive Myositis;Journal of General Internal Medicine;2024-09-09

2. Rapidly progressive myopathy: unveiling light chain amyloidosis as an initial manifestation of multiple myeloma: a case report and literature review;Neuromuscular Disorders;2024-08

3. Skeletal muscle involvement in systemic amyloidosis is often overlooked;Neuropathology and Applied Neurobiology;2024-07-09

4. Current status and prospect of anti-amyloid fibril therapy in AL amyloidosis;Blood Reviews;2024-07

5. Paraproteinemic neuropathies;Muscle & Nerve;2024-05-30